Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy
Luca Liberale, Federico Carbone, Camici, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1764-1764
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Inflammation and cardiovascular diseases: lessons from seminal clinical trials
Luca Liberale, Fabrizio Montecucco, Lena Schwarz, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 2, pp. 411-422
Open Access | Times Cited: 92
Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus
Patryk Graczyk, Aleksandra Dach, Kamil Dyrka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5027-5027
Open Access | Times Cited: 11
Progress in the treatment of diabetic cardiomyopathy, a systematic review
Yiyi Shou, X M Li, Quan Fang, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents
Federico Carbone, Aldo Bonaventura, Luca Liberale, et al.
Clinical Reviews in Allergy & Immunology (2018) Vol. 58, Iss. 1, pp. 1-14
Closed Access | Times Cited: 61
Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
Namrita Kaur, Yingshu Guan, Rida Raja, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 48
IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction
Jianwu Huang, Wenlong Kuang, Zihua Zhou
Inflammopharmacology (2024)
Closed Access | Times Cited: 7
The Dynamic Feature of Macrophage M1/M2 Imbalance Facilitates the Progression of Non-Traumatic Osteonecrosis of the Femoral Head
Zhen Tan, Yan Wang, Yingqi Chen, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 26
The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Kai Ding, Chao Song, Heng-Jing Hu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 23
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment
Alpo Vuorio, Frederick J. Raal, Markku Kaste, et al.
Atherosclerosis (2021) Vol. 320, pp. 53-60
Open Access | Times Cited: 31
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues
Miriam Longo, Lorenzo Scappaticcio, Paolo Cirillo, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 272-272
Open Access | Times Cited: 22
Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets
Wanlin Ye, Kun Han, Maodi Xie, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 8, pp. 936-948
Open Access | Times Cited: 4
Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
Alpo Vuorio, Petri T. Kovanen
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 23
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
Chin‐Feng Hsuan, Sean I. F. Teng, Chih‐Neng Hsu, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 662-662
Open Access | Times Cited: 8
Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization
Xianmin Song, Mengnan Zhao, Guizhi Li, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 12, pp. 1849-1861
Open Access | Times Cited: 8
Role of Nrf2 and Its Activators in Cardiocerebral Vascular Disease
Liangkai Cheng, Hong Zhang, Fang Wu, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 18
Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage
Edoardo Elia, Stefano Ministrini, Federico Carbone, et al.
Minerva Cardiology and Angiology (2022) Vol. 70, Iss. 3
Closed Access | Times Cited: 11
Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors
Katja Hrovat, Andreja Rehberger Likozar, Janja Zupan, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 7, pp. 211-211
Open Access | Times Cited: 10
Anti-inflammatory effects of non-statin low-density lipoprotein cholesterol-lowering drugs: an unused potential?
Anders Hovland, Kjetil Retterstøl, Tom Eirik Mollnes, et al.
Scandinavian Cardiovascular Journal (2020) Vol. 54, Iss. 5, pp. 274-279
Open Access | Times Cited: 12
Bufalin reduces myocardial infarction‐induced myocardial fibrosis and improves cardiac function by inhibiting the NLRP3/IL‐1β signalling pathway
Wei Xiang, Yang Lv, Chenxi Yang, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 8, pp. 688-697
Open Access | Times Cited: 4
The latest emerging drugs for the treatment of diabetic cardiomyopathy
Minghao Li, Lin Liu, Chunyu Zhang, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 641-654
Closed Access | Times Cited: 1
Who Is Afraid of CRP? Elevated Preoperative CRP Levels Might Attenuate the Increase in Inflammatory Parameters in Response to Lung Cancer Surgery
Moritz Mecki Meyer, Leon Brandenburg, Helge Hudel, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3340-3340
Open Access | Times Cited: 9
Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.
Shuo Cong, Chrishan J. A. Ramachandra, Kp Myu Mai Ja, et al.
PubMed (2020) Vol. 3, Iss. 2, pp. 82-97
Closed Access | Times Cited: 9
A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy
Jyotsna Needamangalam Balaji, Sreenidhi Prakash, Ashish Joshi, et al.
Clinics and Practice (2022) Vol. 12, Iss. 4, pp. 565-578
Open Access | Times Cited: 4
Rosuvastatin accelerates the healing process of partial-thickness burn wounds in rats by reducing TNF-α levels
Alexandra Marneri, Francesk Mulita, Vasileios Leivaditis, et al.
Archives of Medical Science - Atherosclerotic Diseases (2024) Vol. 9, Iss. 1, pp. 226-240
Open Access
In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite Nanoparticles
Banafsheh Rastegari, Atefe Ghamar Talepoor, Shahdad Khosropanah, et al.
ACS Omega (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top